Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-22

Clinical Trial Update: Non-Invasive Neuromodulation for Upper Extremity Function in Spinal Cord Injury: A Crossover Trial [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/Phase 3 crossover trial evaluating non-invasive neuromodulation to improve upper-extremity function in cervical spinal cord injury, currently recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Spinal Cord Injury Cervical | Phase 2, Phase 3 | Status: RECRUITING